Yang-ling Li
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer therapeutics and mechanisms 4
- Protein Tyrosine Phosphatases 2
- Kruppel-like factors research 2
- Oncology 12
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
- Co-authors
- Chong Zhang (16 shared papers)Lin‐wen Wu (9 shared papers)Nengming Lin (8 shared papers)Linghui Zeng (6 shared papers)Xiu Hu (5 shared papers)Qiaojun He (1 shared paper)Meidan Ying (1 shared paper)Xiaotian Qi (1 shared paper)
- Journals
- Acta Pharmacologica Sinica (2 papers)Phytomedicine (2 papers)Cancer Cell International (2 papers)eLife (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Yang-ling Li
19 papers receiving 348 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 102
- Toxicology 13
- Molecular Biology 229
- Oncology 82
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Yang-ling Li
This map shows the geographic impact of Yang-ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang-ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang-ling Li more than expected).
Fields of papers citing papers by Yang-ling Li
This network shows the impact of papers produced by Yang-ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang-ling Li. The network helps show where Yang-ling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang-ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 94 | |
| 2 | 2020 | 65 | |
| 3 | 2018 | 24 | |
| 4 | 2016 | 22 | |
| 5 | 2018 | 22 | |
| 6 | 2018 | 19 | |
| 7 | 2020 | 15 | |
| 8 | 2016 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2016 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2024 | 7 | |
| 15 | 2019 | 5 | |
| 16 | 2021 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2016 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 0 |
About Yang-ling Li
Yang-ling Li is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Immunology, having authored 22 papers that have together received 350 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers), Quinazolinone synthesis and applications (2 papers), Protein Tyrosine Phosphatases (2 papers), Kruppel-like factors research (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (102 citations), Toxicology (13 citations), Molecular Biology (229 citations), Oncology (82 citations) and Pulmonary and Respiratory Medicine (77 citations). Yang-ling Li has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Chong Zhang, Lin‐wen Wu, Nengming Lin, Linghui Zeng, Xiu Hu, Qiaojun He, Meidan Ying, Xiaotian Qi, Bin Lü and Yanqi Zhang. Their work appears in journals such as Acta Pharmacologica Sinica, Phytomedicine, Cancer Cell International, eLife and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.